DHP India Ltd files SEBI 29(2) disclosure for share acquisition in Counter Cyclical Investment Pvt Ltd

What DHP India Ltd announced

On 18 June 2026, DHP India Ltd (BSE: 531306) filed a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing, submitted to the Bombay Stock Exchange, informs the market that DHP India Ltd has acquired a substantial shareholding in Counter Cyclical Investment Pvt Ltd. The filing does not contain any narrative beyond the statutory statement of the acquisition.

Details of the disclosure

The filing, titled Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 for Counter Cyclical Investment Pvt Ltd, was uploaded as a PDF on BSE’s corporate filing portal. The document follows the standard format prescribed by SEBI, indicating that the acquisition meets the threshold that requires public disclosure (generally 1% of the share capital or any subsequent increase of 0.5%). No quantitative data—such as the number of shares acquired, percentage of equity, or monetary consideration—was provided in the excerpt available.

Key facts at a glance

Why this matters for investors

Regulation 29(2) obliges listed entities to disclose any acquisition that crosses the statutory thresholds, ensuring transparency for shareholders and the market. By filing, DHP India Ltd complies with SEBI’s disclosure regime, signalling that the transaction is material enough to warrant public notice. However, because the filing omits the size of the stake and the financial terms, investors cannot yet assess the impact on DHP’s balance sheet, earnings, or strategic direction. Any future announcements—such as board approvals, financing details, or integration plans—will provide clearer insight into how the acquisition aligns with DHP’s growth objectives.

Conclusion

DHP India Ltd has formally disclosed a substantial share acquisition in Counter Cyclical Investment Pvt Ltd under SEBI’s SAST rules. While the filing satisfies regulatory requirements, it does not reveal the scale or financial terms of the deal. Investors should monitor subsequent filings for additional details that could clarify the strategic rationale and financial implications of the transaction.